Literature DB >> 12472479

Results of surgical treatment for recurrent postoperative gastroesophageal reflux.

I Braghetto1, A Csendes, P Burdiles, F Botero, O Korn.   

Abstract

The rate of recurrence of reflux esophagitis after classic antireflux surgery (fundoplication) is 10-15%. This rate is different in patients with esophagitis with and without Barrett's esophagus. We evaluated the clinical and laboratory findings in 104 patients with postoperative recurrent reflux esophagitis, determining the results of repeat antireflux surgery or an acid suppression-bile diversion procedure. Repeat fundoplication was performed in 26 patients, and truncal vagotomy, antrectomy, and Roux-en-Y gastrojejunostomy in 78 patients. Esophagectomy as a third operation was performed in seven patients. After repeat antireflux surgery, endoscopic evaluation demonstrated improvement of esophagitis in a small proportion of patients. Barrett's esophagus remained unchanged, and no regression of ulcer or stricture was observed. These complications improved significantly after acid suppression-bile diversion surgery. Incompetent lower esophageal sphincter (LES) was present in 55.8% after initial surgery and in 23% after reoperation. Acid reflux, initially present in 94.6% of patients, was also observed in 93.6% after fundoplication, 68.8% after redo fundoplication, and 16.6% after treatment with the acid suppression-bile diversion technique. A positive Bilitec test was present in 78% of patients before the operation and 56.6% after the repeat operation, and was negative after bile diversion surgery. Among 13 patients (50%) submitted to repeat surgery alone, esophagectomy as a third operation was necessary as a result of severe non-dilatable stricture in seven patients. Our conclusions are that repeat antireflux surgery alone failed to improve Barrett's esophagus complications and that the best results were obtained in patients submitted to acid suppression-bile diversion surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12472479     DOI: 10.1046/j.1442-2050.2002.00274.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Roux-en-Y reconstruction is superior to redo fundoplication in a subset of patients with failed antireflux surgery.

Authors:  Sumeet K Mittal; András Légner; Kazuto Tsuboi; Arpad Juhasz; Lokesh Bathla; Tommy H Lee
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

2.  Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study.

Authors:  Italo Braghetto; Owen Korn; Attila Csendes; Luis Gutiérrez; Héctor Valladares; Max Chacon
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

3.  Long-term outcomes of reintervention for failed fundoplication: redo fundoplication versus Roux-en-Y reconstruction.

Authors:  Se Ryung Yamamoto; Masato Hoshino; Kalyana C Nandipati; Tommy H Lee; Sumeet K Mittal
Journal:  Surg Endosc       Date:  2013-10-03       Impact factor: 4.584

4.  Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997-2005.

Authors:  Peter Funch-Jensen; Anette Bendixen; Maria Gerding Iversen; Henrik Kehlet
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

Review 5.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  LAPAROSCOPIC REDO FUNDOPLICATION ALONE, REDO NISSEN FUNDOPLICATION, OR TOUPET FUNDOPLICATION COMBINED WITH ROUX-EN-Y DISTAL GASTRECTOMY FOR TREATMENT OF FAILED NISSEN FUNDOPLICATION.

Authors:  Italo Braghetto; Owen Korn; Manuel Figueroa-Giralt; Catalina Valenzuela; Ana Maria Burgos; Carlos Mandiola; Camila Sotomayor; Eduardo Villa
Journal:  Arq Bras Cir Dig       Date:  2022-09-09

Review 7.  Surgical reintervention after failed antireflux surgery: a systematic review of the literature.

Authors:  Edgar J B Furnée; Werner A Draaisma; Ivo A M J Broeders; Hein G Gooszen
Journal:  J Gastrointest Surg       Date:  2009-04-04       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.